These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6078488

  • 1. Prognosis of schizophrenia before and after pharmacotherapy: I. Short term outcome.
    Pritchard M.
    Br J Psychiatry; 1967 Dec; 113(505):1345-52. PubMed ID: 6078488
    [No Abstract] [Full Text] [Related]

  • 2. Prognosis of schizophrenia before and after pharmacotherapy: II. Three-year follow-up.
    Pritchard M.
    Br J Psychiatry; 1967 Dec; 113(505):1353-9. PubMed ID: 6078489
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [PHARMACOTHERAPY OF SCHIZOPHRENIA. I. PHARMACOTHERAPY WITH IN-PATIENTS OF SHORT-TERM ADMISSION].
    HACHIYA H.
    Seishin Shinkeigaku Zasshi; 1964 Jan; 66():45-66. PubMed ID: 14113313
    [No Abstract] [Full Text] [Related]

  • 5. The effect of chlorpromazine and reserpine on sedation and convulsive thresholds in schizophrenic patients.
    BRADLEY PB, JEAVONS PM.
    Electroencephalogr Clin Neurophysiol; 1957 Nov; 9(4):661-72. PubMed ID: 13480239
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The Wartegg-Sign-Test in schizophrenics].
    Knorr W, Rennert H.
    Fortschr Neurol Psychiatr Grenzgeb; 1966 May; 34(5):276-96. PubMed ID: 5339269
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential effects of chlorpromazine and reserpine.
    PEARL D, HERMAN L, VANDER KAMP H, OLSEN A, ARMITAGE SG.
    Psychiatr Q; 1958 Jul; 32(3):565-73. PubMed ID: 13623931
    [No Abstract] [Full Text] [Related]

  • 11. A controlled clinical study of chlorpromazine and reserpine in chronic schizophrenia.
    SHEPHERD M, WATT DC.
    J Neurol Neurosurg Psychiatry; 1956 Aug; 19(3):232-5. PubMed ID: 13357965
    [No Abstract] [Full Text] [Related]

  • 12. Insulin and chlorpromazine in schizophrenia: a ten year comparative survey.
    Markowe M, Steinert J, Heyworth-Davis F.
    Br J Psychiatry; 1967 Oct; 113(503):1101-6. PubMed ID: 6057379
    [No Abstract] [Full Text] [Related]

  • 13. Reserpine and chlorpromazine in the treatment of chronic schizophrenics.
    WATT DB.
    Encephale; 1956 Oct; 45(4):661-2. PubMed ID: 13384279
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Study of the differential behavioral effects of reserpine, chlorpromazine, and a combination of these drugs in chronic schizophrenic patients.
    BARRETT WW, ELLSWORTH RB, CLARK LD, ENNISS J.
    Dis Nerv Syst; 1957 Jun; 18(6):209-15. PubMed ID: 13427660
    [No Abstract] [Full Text] [Related]

  • 19. Schizophrenic patients in 1950-1952 and 1957-1959. A comparative study.
    Achté KA, Apo M.
    Psychiatr Q; 1967 Jul; 41(3):422-41. PubMed ID: 4294876
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.